首页> 外文期刊>American Journal of PharmTech Research >FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF TIMOLOL MALEATE AS A MODEL DRUG.
【24h】

FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF TIMOLOL MALEATE AS A MODEL DRUG.

机译:作为模型药物的苹果酸密莫洛尔经皮给药系统的设计与评价。

获取原文
           

摘要

ABSTRACT Timolol maleate, an antihypertensive drug has a half-life of 2-3 hours and a bioavailability of about 60%. It undergoes extensive first pass metabolism. The present study aims to formulate and evaluate Transdermal drug delivery for sustained release of Timolol maleate. The partition coefficient in octanol /water system indicates that the drug is suitable for Transdermal drug delivery. The Physicochemical compatibility of the drug and polymers was studied by IR spectroscopy and the results suggested no physicochemical incompatibility between drugs and the polymers. Total 20 formulations were prepared. The transdermal patches were prepared using different polymers like Hydroxy Propyl Methyl Cellulose, Polyvinyl alcohol and Poly vinyl pyrrolidine in varied ratios, plasticizers like propylene glycol and various permeation enhancers. The patches were evaluated for various parameters like Thickness, weight variation, Water-Vapor Permeability, Tensile Strength, Percent Moisture Uptake, Drug Content, Diffusion and Dissolution studies. The interaction among various components of the matrices was studied by performing Differential Scanning Calorimetry. The Optimized formulation containing PVA: PVP (F 19) in the ratio of 3:2 and containing 30 % propylene glycol as a plasticizer and 2 % Hyaluronidase as a permeation enhancer gave a maximum release 51.68 % (4.75 mg) over a period of 8 hours. Stability studies were carried out as per ICH guidelines and formulations were found to be Stable. Key words: Transdermal patches; Timolol maleate; Differential Scanning Calorimetry (DSC); Infrared spectroscopy (IR); Partition co-efficient.  
机译:摘要马来酸替莫洛尔是一种降压药,半衰期为2-3小时,生物利用度约为60%。它经历了广泛的首过代谢。本研究旨在制定和评估缓释马来酸替莫洛尔的透皮给药方法。辛醇/水系统中的分配系数表明该药物适用于透皮给药。通过红外光谱研究了药物和聚合物的理化相容性,结果表明药物和聚合物之间没有理化不相容性。共制备了20种配方。所述透皮贴剂是使用不同比例的聚合物如羟丙基甲基纤维素,聚乙烯醇和聚乙烯吡咯烷,增塑剂如丙二醇和各种渗透促进剂制备的。对贴剂的各种参数进行了评估,例如厚度,重量变化,水蒸气的渗透性,拉伸强度,水分吸收百分比,药物含量,扩散和溶出度研究。通过执行差示扫描量热法研究了矩阵的各个组成部分之间的相互作用。含有比例为3:2的PVA:PVP(F 19)且包含30%丙二醇作为增塑剂和2%透明质酸酶作为渗透促进剂的优化配方在8个周期内最大释放51.68%(4.75 mg)小时。按照ICH指南进行稳定性研究,发现制剂稳定。关键词:透皮贴剂马来酸替莫洛尔;差示扫描量热法(DSC);红外光谱(IR);分配系数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号